Long-term outcome of centrally located low-grade glioma in children

Cancer

Volumn 119, Issue 14, 2013, Pages 2630-2638

  Terashima, Keita ^a   Chow, Kevin ^a   Jones, Jeremy ^b   Ahern, Charlotte ^c   Jo, Eunji ^c   Ellezam, Benjamin ^a   Paulino, Arnold C ^d   Okcu, M Fatih ^a   Su, Jack ^a   Adesina, Adekunle ^a   Mahajan, Anita ^e   Dauser, Robert ^a   Whitehead, William ^a   Lau, Ching ^a   Chintagumpala, Murali ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Dan L Duncan Cancer Center   (United States)

^c Dan L Duncan Cancer Center   (United States)

^d HOUSTON METHODIST HOSPITAL   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

BRAF KIAA1549 fusion protein; chemotherapy; childhood cerebral astrocytoma; childhood optic nerve glioma; hypothalamic chiasmatic neoplasms; long term effects; pilocytic astrocytoma; radiotherapy

Indexed keywords

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; EARLY DIAGNOSIS; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; GLIOMA; HUMAN; INFANT; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RISK ASSESSMENT; SCHOOL CHILD;

BRAF-KIAA1549 FUSION PROTEIN; CHEMOTHERAPY; CHILDHOOD CEREBRAL ASTROCYTOMA; CHILDHOOD OPTIC NERVE GLIOMA; HYPOTHALAMIC-CHIASMATIC NEOPLASMS; LONG-TERM EFFECTS; PILOCYTIC ASTROCYTOMA; RADIOTHERAPY;

ADOLESCENT; AFFECTIVE SYMPTOMS; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; DISEASE-FREE SURVIVAL; ENDOCRINE SYSTEM DISEASES; FEMALE; GLIOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KAPLAN-MEIER ESTIMATE; MALE; MEDICAL RECORDS; NEOPLASM GRADING; NERVOUS SYSTEM DISEASES; ONCOGENE PROTEINS, FUSION; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVORS; TEXAS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VISION DISORDERS;

EID: 84879661588     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28110     Document Type: Article

References (34)

1. Sievert AJ, Fisher MJ,. Pediatric low-grade gliomas. J Child Neurol. 2009; 24: 1397-1408.
2. Garvey M, Packer RJ,. An integrated approach to the treatment of chiasmatic-hypothalamic gliomas. J Neurooncol. 1996; 28: 167-183.
3. Packer RJ, Ater J, Allen J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg. 1997; 86: 747-754.
4. Packer RJ, Lange B, Ater J, et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol. 1993; 11: 850-856.
5. Petronio J, Edwards MS, Prados M, et al. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg. 1991; 74: 701-708.
6. Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA., Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol. 1997; 32: 235-241.
7. Jones DT, Kocialkowski S, Liu L, et al. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res. 2008; 68: 8673-3677.
8. Sievert AJ, Jackson EM, Gai X, et al. Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol. 2009; 19: 449-458.
9. Forshew T, Tatevossian RG, Lawson AR, et al. Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol. 2009; 218: 172-181.
10. Gronych J, Korshunov A, Bageritz J, et al. An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice. J Clin Invest. 2011; 121: 1344-1348.
11. Hawkins C, Walker E, Mohamed N, et al. BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma. Clin Cancer Res. 2011; 17: 4790-4798.
12. Takei H, Nguyen Y, Mehta V, Chintagumpala M, Dauser RC, Adesina AM,. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation. J Neurosurg Pediatr. 2009; 3: 61-65.
13. Gajjar A, Sanford RA, Heideman R, et al. Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol. 1997; 15: 2792-2799.
14. Fisher PG, Tihan T, Goldthwaite PT, et al. Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer. 2008; 51: 245-250.
15. Stokland T, Liu JF, Ironside JW, et al. A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro Oncol. 2010; 12: 1257-1268.
16. Gnekow AK, Kortmann RD, Pietsch T, Emser A,. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy-report from the multicenter treatment study for children and adolescents with a low grade glioma-HIT-LGG 1996-of the Society of Pediatric Oncology and Hematology (GPOH). Klin Padiatr. 2004; 216: 331-342.
17. Ater JL, Zhou T, Holmes E, et al. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group. J Clin Oncol. 2012; 30: 2641-2647.
18. Sutton LN, Molloy PT, Sernyak H, et al. Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg. 1995; 83: 583-589.
19. Jeuken JW, Wesseling P,. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential. J Pathol. 2010; 222: 324-328.
20. Merchant TE, Kun LE, Wu S, Xiong X, Sanford RA, Boop FA,. Phase II trial of conformal radiation therapy for pediatric low-grade glioma. J Clin Oncol. 2009; 27: 3598-3604.
21. Merchant TE, Conklin HM, Wu S, Lustig RH, Xiong X,. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol. 2009; 27: 3691-3697.
22. Aarsen FK, Paquier PF, Reddingius RE, et al. Functional outcome after low-grade astrocytoma treatment in childhood. Cancer. 2006; 106: 396-402.
23. Aarsen FK, Paquier PF, Arts WF, et al. Cognitive deficits and predictors 3 years after diagnosis of a pilocytic astrocytoma in childhood. J Clin Oncol. 2009; 27: 3526-3532.
24. Armstrong GT, Conklin HM, Huang S, et al. Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro Oncol. 2011; 13: 223-234.
25. Ris MD, Beebe DW, Armstrong FD, et al. Cognitive and adaptive outcome in extracerebellar low-grade brain tumors in children: a report from the Children's Oncology Group. J Clin Oncol. 2008; 26: 4765-4770.
26. Shofty B, Ben-Sira L, Freedman S, et al. Visual outcome following chemotherapy for progressive optic pathway gliomas. Pediatr Blood Cancer. 2011; 57: 481-485.
27. Campagna M, Opocher E, Viscardi E, et al. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1. Pediatr Blood Cancer. 2010; 55: 1083-1088.
28. Collet-Solberg PF, Sernyak H, Satin-Smith M, et al. Endocrine outcome in long-term survivors of low-grade hypothalamic/chiasmatic glioma. Clin Endocrinol (Oxf). 1997; 47: 79-85.
29. Shalitin S, Gal M, Goshen Y, Cohen I, Yaniv I, Phillip M,. Endocrine outcome in long-term survivors of childhood brain tumors. Horm Res Paediatr. 2011; 76: 113-122.
30. Brauner R, Malandry F, Rappaport R, et al. Growth and endocrine disorders in optic glioma. Eur J Pediatr. 1990; 149: 825-828.
31. Gleeson HK, Shalet SM,. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocr Relat Cancer. 2004; 11: 589-602.
32. Kirsch DG, Tarbell NJ,. Conformal radiation therapy for childhood CNS tumors. Oncologist. 2004; 9: 442-450.
33. Fisher BJ, Leighton CC, Vujovic O, Macdonald DR, Stitt L,. Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas. Int J Radiat Oncol Biol Phys. 2001; 51: 704-710.
34. Pfister S, Janzarik WG, Remke M, et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest. 2008; 118: 1739-1749.